Valuation: Avinger, Inc.

Market Cap 2.71M 2.41M 2.24M 2.05M 3.86M 260M 3.89M 27.17M 10.53M 133M 10.16M 9.94M 427M P/E 2022
-0.25x
P/E 2023 -0.19x
Enterprise Value 12.83M 11.4M 10.64M 9.7M 18.29M 1.23B 18.46M 129M 49.88M 630M 48.16M 47.11M 2.02B EV / Sales 2022
1.19x
EV / Sales 2023 1.78x
Free-Float
88.44%
Yield 2022 *
-
Yield 2023 -
3 years 0.36
Extreme 0.363
6.55
5 years 0.36
Extreme 0.363
288.9
10 years 0.36
Extreme 0.363
618,002.47
Manager TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer - 04/08/2024
Date Insider Type Main position Quantity % Market Cap. Importance
23/01/25 Sell

Founder

2,215 0.0669%
23/01/25 Sell

Chief Financial Officer

1,255 0.0379%
23/01/25 Sell

Chief Executive Officer

3,690 0.1115%
Change 5-day change 1-year change 3-year change Capi.($)
-20.74%-.--%-.--%-90.97% 1.52M
+0.35%-2.99%+20.52%+31.06% 242B
+1.09%-4.65%-0.43%-0.76% 150B
-2.32%-3.27%-13.35%+36.07% 138B
-1.46%-3.01%-56.23%-17.35% 61.74B
-0.05%-1.32%+10.48%+22.34% 49.08B
+0.66%+0.19%-20.53%-20.70% 47.43B
+0.66%-2.90%+18.46%+52.17% 47.3B
-3.05%-2.62%-7.75%+36.49% 44.25B
-0.08%-1.92%+29.48%+60.45% 41.78B
Average -2.49%-0.17%-1.93%+10.88% 82.26B
Weighted average by Cap. -0.29%-3.27%+1.08%+21.95%

Financials

2022 2023
Net sales 8.27M 7.35M 6.86M 6.25M 11.79M 795M 11.9M 83.02M 32.17M 407M 31.06M 30.39M 1.3B 7.65M 6.8M 6.35M 5.78M 10.91M 736M 11.01M 76.79M 29.76M 376M 28.73M 28.11M 1.21B
Net income -17.62M -15.66M -14.61M -13.32M -25.12M -1.69B -25.36M -177M -68.53M -866M -66.17M -64.73M -2.78B -18.32M -16.28M -15.19M -13.85M -26.12M -1.76B -26.36M -184M -71.24M -900M -68.78M -67.29M -2.89B
Net Debt 1.76M 1.56M 1.46M 1.33M 2.5M 169M 2.53M 17.62M 6.83M 86.3M 6.59M 6.45M 277M 10.12M 8.99M 8.39M 7.65M 14.43M 973M 14.56M 102M 39.35M 497M 38M 37.17M 1.6B
Logo Avinger, Inc.
Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.
Employees
70
  1. Stock Market
  2. Stocks
  3. AVGR Stock